menu
    • menu

    Company profile for Sentinel Oncology

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a drug discovery company specialising in the development of novel therapeutics to treat patients for whom there is an unmet medical need. From initial concept to the delivery of candidate drugs - we're a drug discovery company specialising in cutting-edge treatments for diseases with an unmet need. Sentinel Oncology was founded in 2005 in Cambridge, UK and is a drug discovery company dedicated to the development and com...
    We are a drug discovery company specialising in the development of novel therapeutics to treat patients for whom there is an unmet medical need. From initial concept to the delivery of candidate drugs - we're a drug discovery company specialising in cutting-edge treatments for diseases with an unmet need. Sentinel Oncology was founded in 2005 in Cambridge, UK and is a drug discovery company dedicated to the development and commercialisation of new therapeutics to treat patients for whom there is currently an unmet medical need.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sentinel Oncologyunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Sentinel Oncology Limited 20 Station Road, Cambridge CB1 2JD
    Telephone
    Telephone
    +44 (0)1223 653 209
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sentineloncology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sentinel-oncology-limited
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/senoncology

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    The McQuade Center Enters Agreement with Sentinel Oncology
    The McQuade Center Enters Agreement with Sentinel Oncology

    02 Sep 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210902005442/en

    BUSINESSWIRE
    02 Sep 2021
    Share Share
    PharmaEngine,and Sentinel Oncology Limited Enter into an Exclusive Collaboration
    PharmaEngine,and Sentinel Oncology Limited Enter into an Exclusive Collaboration

    04 Dec 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/pharmaengine-inc-and-sentinel-oncology-limited-enter-into-an-exclusive-collaboration-and-license-agreement-for-sol-578-a-chk1-inhibitor-301186436.html#:~:text=(TWO%3A%204162)%20announced%20today,enabling%20studies%20for%20SOL%2D578.

    PRNEWSWIRE
    04 Dec 2020
    Share Share
    PharmaEngine, & Sentinel Oncology Limited Enter into SOL-578
    PharmaEngine, & Sentinel Oncology Limited Enter into SOL-578

    04 Dec 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/pharmaengine-inc-and-sentinel-oncology-limited-enter-into-an-exclusive-collaboration-and-license-agreement-for-sol-578-a-chk1-inhibitor-301186436.html

    PRNEWSWIRE
    04 Dec 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search